The production of retatrutide, a novel dual activator targeting both GLP-1 and GIP receptors, represents a complex multi-step synthetic process. Early routes focused on protein portion coupling, utilizing solid-phase production methodologies to build the long amino acid sequence. Subsequent investigation has explored alternative approaches, includi